Article
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.
Scientific reports - 13 Dec 2013
Wong Stephen Q, Li Jason, Salemi Renato, Sheppard Karen E, Do Hongdo, Tothill Richard W, McArthur Grant A, Dobrovic Alexander
Abstract excerpt
Massively parallel sequencing offers the ability to interrogate a tumour biopsy for multiple mutational changes. For clinical samples, methodologies must enable maximal extraction of available sequence information from formalin-fixed and paraffin-embedded (FFPE) material. We assessed the use of targeted capture for mutation detection in FFPE DNA. The capture probes targeted the coding region of all known kinase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
